Editions:  Austria · Denmark · France · Germany · Italy · Norway · Spain · Sweden · Switzerland
Advertisement

Bayer develops 'vaginal atrophy' drug

Share this article

Bayer develops 'vaginal atrophy' drug
Actors in the German film 'Wolke 9,' which explores sex and ageing. Photo: DPA
11:00 CEST+02:00
German pharmaceutical giant Bayer is developing a kind of female Viagra in the form of a new treatment for post-menopausal women experiencing vaginal atrophy that can lead to sexual dysfunction.

The firm signed a deal Tuesday with Quebec's EndoCeutics to develop the treatment, provisionally named Vaginorm, which will boost the steroid DHEA in women's bodies.

DHEA levels naturally drop as people age. For women, that can mean vaginal tissues change and become drier, which can lead to discomfort or even pain during sex.

The deal covers the Phase III clinical development, and the marketing, of the new drug.

With the baby boomer generation nearing retirement age, pharmaceutical companies are keen to find a treatment for sexual dysfunction in older women to match the success of Viagra and other drugs for men.

EndoCeutics said it hoped to improve the quality of life of some 360 million women worldwide aged 50 or older who it said have vaginal atrophy or dryness.

AFP/dw

Get notified about breaking news on The Local

Share this article

Advertisement

From our sponsors

The Swedish university where students tackle real-world problems

Ranked among the world's best young universities in the QS Top 50 Under 50, Linköping University (LiU) uses innovative learning techniques that prepare its students to tackle the challenges of tomorrow.

Advertisement
Advertisement
Jobs
Click here to start your job search
Advertisement
Advertisement

Popular articles

Advertisement
Advertisement